An extension of the PSMA-positive tumor volume method is based on the estimation of the total lesion PSMA (TLP) expression, which should reflect the total tumor burden, additionally taking into account the uptake intensity of individual lesions. The gene discussed is FOLH1; the disease is neoplasm.